Ponatinib 15mg Tablet, Certification : Classic

₹ 45,000 - ₹ 60,000 / Box

MaterialGood
Brand NamePonatinib 45mg Tablet
FormTablet
Packaging SizeCarton
Supply TypeManufacturer, Exporter, Supplier, Retailer, Distributor, Importer, Trader, Buying House
Preferred Buyer Location All over the world

Company Information

4.0/5

Member Since 4 Years
Nature of Business Retailer
GST No. 09AANFV2055P1ZE

Ask for more detail from the seller

Report incorrect details

Product Details
Company Details

FormTablet
MaterialGood
Packaging SizeCarton
ApplicationNew
Brand NamePonatinib 45mg Tablet
Shelf Life3 years
CertificationClassic
Brand name :Iclusig 45 Mg Ponatinib Tablet

Product Specifications

Tablet

Prescription/Non prescription

Prescription

Packaging Size

Bottle of 30 Tablets

Strength

45 mg

Brand

Iclusig

Composition

Ponatinib

Treatment

Cancer

Deals in

PCD Pharma

Product Description

Iclusig Ponatinib is used to treat certain types of blood cancer (chronic myelogenous leukemia-CML, acute lymphoblastic leukemia-ALL).Iclusig is a kinase inhibitor indicated for the treatment of adult patients with chronic phase, accelerated phase, or blast phase chronic myeloid leukemia (CML) that is resistant or intolerant to prior tyrosine kinase inhibitor therapy or Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ALL) that is resistant or intolerant to prior tyrosine kinase inhibitor therapy (1).This indication is based upon response rate. There are no trials verifying an improvement in disease-related symptoms or increased survival with Iclusig